Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report (Q33739945)

29 July 2017

1 reference

title

Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report (English)

1 reference

29 July 2017

0 references

Moran A

1 reference

29 July 2017

Hardin D

1 reference

29 July 2017

Rodman D

1 reference

29 July 2017

Allen HF

1 reference

29 July 2017

Beall RJ

1 reference

29 July 2017

Borowitz D

1 reference

29 July 2017

Brunzell C

1 reference

29 July 2017

Campbell PW 3rd

1 reference

29 July 2017

Chesrown SE

1 reference

29 July 2017

Duchow C

1 reference

29 July 2017

Fink RJ

1 reference

29 July 2017

Fitzsimmons SC

1 reference

29 July 2017

Hamilton N

1 reference

29 July 2017

Hirsch I

1 reference

29 July 2017

Howenstine MS

1 reference

29 July 2017

Klein DJ

1 reference

29 July 2017

Madhun Z

1 reference

29 July 2017

Pencharz PB

1 reference

29 July 2017

Quittner AL

1 reference

29 July 2017

Robbins MK

1 reference

29 July 2017

Schindler T

1 reference

29 July 2017

Schissel K

1 reference

29 July 2017

Schwarzenberg SJ

1 reference

29 July 2017

Stallings VA

1 reference

29 July 2017

Zipf WB

1 reference

29 July 2017

publication date

1 August 1999

1 reference

Diabetes Research and Clinical Practice

29 July 2017

published in

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

61-73

1 reference

The changing epidemiology of cystic fibrosis

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Genetic determination of diabetes mellitus in patients with cystic fibrosis. Multicenter Cystic Fibrosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Abnormal glucose metabolism in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Diabetes mellitus associated with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Altered body composition and muscle protein degradation in nutritionally growth-retarded children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Improvement of nutritional status and lung function after long-term nocturnal gastrostomy feedings in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Proteolysis associated with insulin resistance in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Is the lung a 'target organ' in diabetes mellitus?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Glycemic control and cardiopulmonary function in patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Role of autoimmunity in insulinopenia and carbohydrate derangements associated with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Insulin Secretion, Glycosylated Haemoglobin and Islet Cell Antibodies in Cystic Fibrosis Children and Adolescents with Different Degrees of Glucose Tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Diabetes mellitus in cystic fibrosis: genetic and immunological markers.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

The interaction of 2 diseases: diabetes mellitus and cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Pancreatic endocrine function in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Pancreatic alpha and beta cell functions in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Beta cell function, peripheral sensitivity to insulin and islet cell autoimmunity in cystic fibrosis patients with normal glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

First-Phase Insulin Release in Adult Cystic Fibrosis Patients: Correlation with Clinical and Biological Parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Cystic fibrosis associated islet changes may provide a basis for diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Endocrine pancreas in cystic fibrosis: An immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Insulin sensitivity in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Insulin resistance is associated with decreased clinical status in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Identification and treatment of cystic fibrosis-related diabetes. A survey of current medical practice in the U.S.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Glucose tolerance in patients with cystic fibrosis: five year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Oral glucose tolerance testing in cystic fibrosis: correlations with clinical parameters and glycosylated haemoglobin determinations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Four-year follow-up of glucose tolerance and beta-cell function in nondiabetic cystic fibrosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Tolbutamide causes a modest increase in insulin secretion in cystic fibrosis patients with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Effects of tolbutamide on growth and body composition of nondiabetic children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Effect of ATP-sensitive K+ channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Nutritional assessment and management in cystic fibrosis: a consensus report. The Consensus Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

Relative underweight in cystic fibrosis and its prognostic value

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900058-3

7 January 2021

10.1016/S0168-8227(99)00058-3

Identifiers

DOI

1 reference

29 July 2017

1 reference